
|

| |
Track the *RXNRV Index |
 |
|
 | Nervous System Stocks (*RXNRV) |
| |
Nervous System Ideas |
|
|
|
Nervous System Performance |
|
|
|
Nervous System Community |
|
| |
|
Index Description: These medical firms have significant exposure to the treatment of diseases and disorders related to the central nervous system (CNS).
|
|
|
|
|
Today:
1-month:
All-time:
|
-0.6%
+4.8%
+65.8%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.6%
-2.5%
+45.0%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$2.5B
12.0
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ACAD |
$14.15 |
+0.88 |
+6.6% |
6,849,885 |
134% |
$974.7M |
- |
993% |
2% |
2 Alerts (1 News) - View
|
|
|
| ACOR |
$32.16 |
-0.78 |
-2.4% |
419,133 |
70% |
$1.3B |
- |
53% |
-21% |
No Alerts/News
|
|
|
| AMRN |
$7.05 |
-0.09 |
-1.3% |
2,306,191 |
58% |
$1.0B |
- |
11% |
-56% |
No Alerts/News
|
|
|
| AVNR |
$3.34 |
+0.02 |
+0.6% |
1,016,549 |
72% |
$481.7M |
- |
61% |
-18% |
No Alerts/News
|
|
|
| IPXL |
$18.43 |
+0.01 |
+0.1% |
662,818 |
66% |
$1.2B |
- |
28% |
-32% |
1 Alert (1 News) - View
|
|
|
| OMER |
$5.34 |
+0.20 |
+3.9% |
426,955 |
162% |
$133.1M |
- |
46% |
-60% |
1 Alert (0 News) - View
|
|
|
| OREX |
$6.02 |
-0.02 |
-0.3% |
548,377 |
65% |
$559.5M |
- |
94% |
-22% |
1 Alert (0 News) - View
|
|
|
| RGEN |
$8.70 |
-0.15 |
-1.7% |
330,370 |
78% |
$278.1M |
- |
134% |
-10% |
No Alerts/News
|
|
|
| SOMX |
$3.00 |
0.00 |
0.0% |
21,834 |
39% |
$ |
- |
133% |
-45% |
1 Alert (0 News) - View
|
|
|
| TRGT |
$5.54 |
+0.06 |
+1.1% |
192,972 |
97% |
$184.2M |
- |
44% |
0% |
1 Alert (0 News) - View
|
|
|
| VNDA |
$6.94 |
+0.36 |
+5.5% |
823,920 |
210% |
$186.5M |
- |
138% |
-4% |
1 Alert (0 News) - View
|
|
|
| VRX |
$75.38 |
-2.79 |
-3.6% |
1,113,303 |
90% |
$23.7B |
- |
77% |
-4% |
4 Alerts (2 News) - View
|
|
|
| ZGNX |
$1.57 |
-0.03 |
-1.9% |
302,224 |
45% |
$161.2M |
- |
41% |
-52% |
1 Alert (1 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Impax Board of Directors Establishes Compliance Committee IPXL
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 20, 04:05PM from (www.businesswire.com) Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its Board of Directors has established a Compliance Committee
Flag
Post a comment
Pharma M&A – Actavis to Acquire Warner Chilcott FRX MYL TEVA ACT VRX WCRX
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com) On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner
Flag
Post a comment
Mid-Morning Market Update: Markets Fall, Yahoo To Acquire Tumblr RT RAVN TISI YHOO ACAD WBSN PACT
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 10:43AM from (www.benzinga.com) Following the market opening Monday, the Dow traded down 0.16 percent to 15,329.97, while the NASDAQ fell 0.05 percent to
Flag
Post a comment
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal MYL VRX WCRX
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com) Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion
Flag
Post a comment
ACADIA Pharmaceuticals Prices Public Offering of Common Stock ACAD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 15, 08:00AM from (www.businesswire.com) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 8,000,000 shares
Flag
Post a comment
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock ACAD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 04:01PM from (www.businesswire.com) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other
Flag
Post a comment
ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results ACAD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:01PM from (www.businesswire.com) ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet
Flag
Post a comment
Targacept Reports First Quarter 2013 Financial Results TRGT
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 07:35AM from (www.businesswire.com) Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported
Flag
Post a comment
Benzinga Market Primer: Tuesday, May 7 TAP CLF SMG DEO BMC VNO TAXI ACAD HBC FSLR DISCA DTV TRIP NCLH
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 07, 06:29AM from (www.benzinga.com) Futures Flat Following RBA Rate Cut, European Bank Earnings
U.S. equity futures traded near flat following a
Flag
Post a comment
Amarin to Report First Quarter 2013 Results and Host Conference Call on May 9, 2013 AMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 04:13PM from (globenewswire.com) BEDMINSTER, N.J. and DUBLIN, May 3, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company
Flag
Post a comment
Arena Withdraws Application for Weight-Loss Drug Approval in Europe VVUS ARNA OREX
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 03, 08:30AM from (247wallst.com) Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its
Flag
Post a comment
|
|
|